Summary of results from mixed effects models for AHI (n=81) and ESS (n=83)
| Mean (SD) | Coefficient | 95% CI | p Value | Global p value | |
|---|---|---|---|---|---|
| AHI (n=81) | |||||
| Constant | 14.22 | (11.66 to 17.34) | <0.001 | ||
| Relative AHI compared with no treatment | |||||
| No treatment | 14.6 (10.5) | – | – | – | <0.001 |
| SP1 | 10.8 (9.5) | 0.74 | (0.62 to 0.89) | 0.001 | |
| SP2 | 9.7 (8.9) | 0.67 | (0.59 to 0.76) | <0.001 | |
| bMAD | 9.5 (8.4) | 0.64 | (0.55 to 0.76) | <0.001 | |
| ESS (n=83) | |||||
| Constant | 10.65 | (9.64 to 11.66) | <0.001 | ||
| Difference in ESS compared with no treatment | |||||
| No treatment | 10.1 (4.3) | – | – | – | <0.001 |
| SP1 | 8.5 (4.0) | −1.51 | (−2.29 to −0.73) | <0.001 | |
| SP2 | 8.0 (4.1) | −2.15 | (−2.99 to −1.31) | <0.001 | |
| bMAD | 7.7 (3.8) | −2.37 | (−3.22 to −1.53) | <0.001 | |
AHI, Apnoea-Hypopnoea Index; bMAD, bespoke mandibular advancement device; ESS, Epworth Sleepiness Scale.